Le Lézard
Classified in: Health

Successful USFDA inspection of Asymchem Tianjin 2 development and commercial manufacturing facility

TIANJIN, China, Sept. 12, 2018 /PRNewswire/ -- Asymchem, a leading custom manufacturer of intermediates and API's for the life sciences industry, today announced that its Tianjin 2 site, a multi-purpose development and commercial API manufacturing facility, successfully passed the U.S. Food and Drug Administration (USFDA) general GMP reinspection conducted between July 23-26, 2018 with no Form 483 issued.

Speaking to the success of yet another FDA inspection, Dr. Zhou Yan, VP Quality at Asymchem states, "Our teams invest in and conduct continuous improvements to ensure the highest level of compliance and inspection readiness across all Asymchem sites." Asymchem's previous USFDA inspection of the Tianjin 2 site in 2014, as well as the most recent Asymchem Dunhua 1 and Fuxin 1 facilities in March 2017 and March 2018 respectively, also resulted in no Form 483 observations.

Dr. Hao Hong, Chairman and CEO of Asymchem Group, remarked, "I am extremely proud of the result as the Asymchem team proves yet again our robust quality system together with unyielding management commitment meets the highest quality standards in the manufacture of GMP products."

To keep up with increasing demand, Asymchem is expanding the Tianjin 2 site to include peptide manufacturing capability as well as expanding low volume API manufacturing capacity. Both will be operational by late 2018.

About Asymchem
Asymchem is a full service CMC CDMO of API's for the global pharmaceutical industry, providing compliant and sustainable manufacturing solutions worldwide over the lifecycle of a drug. Capabilities include dedicated HPAPI, in-house enzyme evolution and fermentation for biotransformations, end-to-end continuous flow development and application, hydrogenation, cryogenic capabilities, dedicated carbapenem manufacture, and others. Founded in 1997, Asymchem employs 2800 personnel within China over 6 manufacturing sites. Asymchem has a successful history of USFDA, Australian TGA, Chinese cFDA and Korean MFDS inspections.


SOURCE Asymchem

These press releases may also interest you

at 10:30
The 11th Annual DVE Rocks for Children's Radiothon raised a record-breaking $852,539 in support of UPMC Children's Hospital of Pittsburgh. The two-day radiothon broadcasted live from UPMC Children's Hospital on Sept. 20 and 21. The DVE Rocks for...

at 10:30
According to a new market research report "Urgent Care Apps Market by Type (Emergency Care Triage Apps, In-hospital Communication Apps, Post-hospital Apps (Nurse Communication Apps, Rehab Apps, Medication Management Apps)), Clinical Area (Stroke,...

at 10:25
BERKELEY, Calif., Sept. 26, 2018 /PRNewswire-PRWeb/ -- Supportiv, the support network that matches users with peers for anonymous, real-time chats on any mental wellness topic ?from everyday life struggles, anxiety, stress and relationship or work...

at 10:20
Americans depend on the U.S. Food and Drug Administration to help ensure that the foods they buy and consume are safe. When we learn that potentially dangerous food products may be available in the U.S. marketplace, we must move quickly and...

at 10:18
BlueWillow Biologics® today announced the company has been awarded an NIH Small Business Innovation Research (SBIR) grant for the development of an intranasal NanoVax® vaccine for the prevention of chlamydia. There are more than 131 million new...

at 10:17
1 Natural Way, a provider of insurance-covered breast pumps and accessories, is now offering a lactation consultation tele-health service to military families. The complimentary service will be available to military moms with Tricare insurance who...

News published on 12 september 2018 at 19:39 and distributed by: